The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer’s Disease. The gene discussed is KCNN4; the disease is early-onset autosomal dominant Alzheimer disease.